aureobasidium pullulans infection in a patient with chronic lymphocytic leukemia

Clicks: 154
ID: 196428
2013
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #167 of 272 articles by views in mobile information systems

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 272 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Saprophytic fungi are being increasingly recognized as etiologic agents of mycoses in immunosuppressed patients. We report a case of subcutaneous infiltration by Aureobasidium pullulans, likely due to traumatic inoculation, in a neutropenic patient during chemotherapy for chronic lymphocytic leukemia. The patient was treated with amphotericin B deoxycholate but was subsequently switched to itraconazole, which improved the lesion. This case highlights the importance of considering unusual fungal infections in critically ill patients such as those who are immunosuppressed due to chemotherapy. Diagnostic techniques and effective antifungal therapy have improved the prognosis of these cases.
Reference Key
oliveira2013revistaaureobasidium Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Leonardo Rodrigues de Oliveira;Helio Moraes-Souza;Andre Luiz Maltos;Keila Cristina dos Santos;Rodrigo Juliano Molina;Cristina Hueb Barata
Journal mobile information systems
Year 2013
DOI
10.1590/0037-8682-0117-2013
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.